[A randomized controlled study of the VKORC1 and CYP2C9 genotypes in guiding warfarin therapy for pulmonary thromboembolism].
Lists
Only you see this
Abstract
The warfarin stable dose prediction algorithm, containing genetic factors and non-heritage factors, can significantly shorten the adjustment time to reach warfarin stable dose, and reduce the incidence of side effects, and is clinically applicable.
BibTeX
@inproceedings{li2013randomized,
author = {Jie Li and Shuang Liu and Jing-hua Yang and Wei Guo and Zengzhi Wang and Yong Chen and Shenghao Wang},
title = {{[A randomized controlled study of the VKORC1 and CYP2C9 genotypes in guiding warfarin therapy for pulmonary thromboembolism].}},
booktitle = {PubMed},
year = {2013},
}Loading related content...